Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Toyohashi
Clinical trial register · Japan

Clinical Trials in Toyohashi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Toyohashi

18 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Hoffmann-La Roche
Phase 3
380
Toyohashi, Aichi, Ehime, Gunma, Hyōgo, Kyoto, Numakunai, Okayama
2026-06-23
Recruiting
Bristol-Myers Squibb
Phase 3
750
Toyohashi, Funabashi, Tōon, Sapporo, Nishinomiya, Kanazawa, Kamakura, Yokohama
2026-03-12
Recruiting
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
NCT07125417Nonvalvular Atrial Fibrillation, Aspirin, Non-Antithrombotic Therapy, High Bleeding Risk
OCEAN-SHD Study Group
Phase 4
500
Nagoya, Toyohashi, Matsudo, Kitakyushu, Gifu, Sapporo, Isehara, Kawasaki
2025-05-29
Active, closed
Specified Drug-use Surveillance of Fabhalta Capsules
NCT06606314Paroxysmal Nocturnal Hemoglobinuria
Novartis Pharmaceuticals
Observational
132
Handa, Nagoya, Okazaki, Toyohashi, Toyota, Hachinohe, Chiba, Funabashi
2024-09-18
Recruiting
Special Drug Use-results Surveillance of Tafinlar/Mekinist
NCT06262919BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor
Novartis Pharmaceuticals
Observational
110
Nagakute, Nagoya, Toyohashi, Toyota, Daisen, Chiba, Funabashi, Kashiwa
2024-02-09
Active, closed
Bristol-Myers Squibb
Phase 1/2
83
Anjo-shi, Nagoya, Toyohashi, Kamogawa, Kashiwa, Narita, Iizuka, Kitakyushu-shi
2023-11-20
Recruiting
AbbVie
Observational
240
Anjo-shi, Handa, Nagakute, Nagoya, Toyohashi, Toyota-shi, Hachinohe, Kashiwa-shi
2023-07-28
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Toyohashi, Kashiwa-shi, Matsuyama, Chikushino-shi, Iizuka-shi, Kurume-shi, Ota-shi, Fukuyama-shi
2023-01-16
Active, closed
Eisai Co., Ltd.
Observational
145
Komaki-shi, Konan-shi, Nagakute-shi, Nagoya, Okazaki-shi, Seto-shi, Toyohashi, Toyokawa-shi
2021-08-16
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Nagoya, Toyohashi, Kashiwa, Matsuyama, Ōta, Sapporo, Kobe, Yokohama
2020-09-16
Active, closed
Amplatzer Amulet LAAO vs. NOAC
NCT04226547Atrial Fibrillation, Stroke, Bleeding
DrugNOAC
Abbott Medical Devices
Not applicable
2,650
Toyohashi, Chiba, Kitakyushu, Tsukuba, Kamakura, Sendai, Kurashiki-shi, Meguro-ku
2020-07-07
Active, closed
Pfizer
Phase 3
896
Nagoya, Toyohashi, Kashiwa-shi, Nagareyama-shi, Sakura, Fukuoka, Kasuga, Kasuga-shi
2019-09-05
Active, closed
BeOne Medicines
Phase 3
510
Nagoya, Toyohashi, Chiba, Kurume, Hiroshima, Yokohama, Kumamoto, Kyoto
2019-08-20
Active, closed
AbbVie
Phase 3
747
Nagakute, Nagoya, Toyohashi, Hirosaki-shi, Sakura-shi, Chikushino-shi, Kurume-shi, Takasaki-shi
2018-03-21
Active, closed
AbbVie
Phase 3
950
Nagakute, Nagoya, Toyohashi, Toyota-shi, Hirosaki-shi, Abiko-shi, Kashiwa-shi, Sakura-shi
2017-01-31
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-japan/city/toyohashi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Toyohashi.

How many clinical trials are recruiting in Toyohashi?

6 of the 18 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toyohashi), 18 studies
PhaseStudiesRecruitingShare
Phase 310355.6%
Observational5227.8%
Not applicable105.6%
Phase 1/2105.6%
Phase 4115.6%

Most active sponsors

Lead sponsors with the most studies (Toyohashi)
Lead sponsorStudiesRecruiting
AbbVie31
BeOne Medicines20
Bristol-Myers Squibb21
Novartis Pharmaceuticals21
Pfizer21
Abbott Medical Devices10
Abivax S.A.10
ADC Therapeutics S.A.10
Eisai Co., Ltd.10
Hoffmann-La Roche11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.